Medication use provides an ideal opportunity for monitoring quality of care in the vulnerable elders. Because drugs are readily and unambiguously specified, and filled prescriptions and medication lists are increasingly computerized, automated screening is both practical and efficient. Furthermore, unlike many other health care interventions, the evidence base for medication use is often clearly defined, despite the continuing problem of under-representation of vulnerable elderly patients in clinical trials. Therefore, because medication use plays a central role in geriatric practice, taken together these characteristics of drug use make the systematic surveillance of the quality of drug use one of the most promising approaches to improving the care of this important population.
Originally published in: Annals of Internal Medicine, v. 135, no. 8, pt. 2, October 16, 2001, pp. 703-710.
This report is part of the RAND reprint series. The Reprint was a product of RAND from 1992 to 2011 that represented previously published journal articles, book chapters, and reports with the permission of the publisher. RAND reprints were formally reviewed in accordance with the publisher's editorial policy and compliant with RAND's rigorous quality assurance standards for quality and objectivity. For select current RAND journal articles, see External Publications.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.